Acute nicotine administration in Alzheimer's disease: An exploratory EEG study

Verner J. Knott, Christopher Engeland, Erich Mohr, Colleen Mahoney, Vadim Ilivitsky

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Previous findings of cognitive deficits and EEG slowing in Alheimer's patients, together with independent reports of the performance enhancing and electrocortical activating properties of nicotine in normal adults, stimulated this study to examine the acute effects of nicotine on spectrum-analyzed EEG in patients with dementia of the Alzheimer type (DAT). Thirteen patients, 6 currently receiving cholinesterase inhibitor treatment and the remaining being medication free, were administered 2 mg of nicotine polacrilex under randomized, placebo-controlled conditions. Compared to age-regressed EEG norms, the pretreatment EEG spectrums of patients in general were characterized by excessive slow (delta and theta)-wave power, diminished fast (alpha and beta)-wave power and slow mean alpha and total band frequencies. Although postnicotine EEG indices remained within the abnormal range, nicotine, compared to placebo, significantly shifted EEG towards normal values by reducing slow wave (relative delta and theta) power and augmenting fast (relative alpha-1, alpha-2, beta-1) wave power. No differences were observed between treated and nontreated patients in response to nicotine. The results are discussed in relation to cholinergic and brain arousal systems and their relationship to cognitive processes. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish (US)
Pages (from-to)210-220
Number of pages11
JournalNeuropsychobiology
Volume41
Issue number4
DOIs
StatePublished - Jan 1 2000

Fingerprint

Nicotine
Electroencephalography
Alzheimer Disease
Placebos
Tobacco Use Cessation Products
Cholinesterase Inhibitors
Arousal
Cholinergic Agents
Reference Values
Power (Psychology)
Brain

All Science Journal Classification (ASJC) codes

  • Neuropsychology and Physiological Psychology
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Knott, Verner J. ; Engeland, Christopher ; Mohr, Erich ; Mahoney, Colleen ; Ilivitsky, Vadim. / Acute nicotine administration in Alzheimer's disease : An exploratory EEG study. In: Neuropsychobiology. 2000 ; Vol. 41, No. 4. pp. 210-220.
@article{4c6659c918824952abcea209b137c27f,
title = "Acute nicotine administration in Alzheimer's disease: An exploratory EEG study",
abstract = "Previous findings of cognitive deficits and EEG slowing in Alheimer's patients, together with independent reports of the performance enhancing and electrocortical activating properties of nicotine in normal adults, stimulated this study to examine the acute effects of nicotine on spectrum-analyzed EEG in patients with dementia of the Alzheimer type (DAT). Thirteen patients, 6 currently receiving cholinesterase inhibitor treatment and the remaining being medication free, were administered 2 mg of nicotine polacrilex under randomized, placebo-controlled conditions. Compared to age-regressed EEG norms, the pretreatment EEG spectrums of patients in general were characterized by excessive slow (delta and theta)-wave power, diminished fast (alpha and beta)-wave power and slow mean alpha and total band frequencies. Although postnicotine EEG indices remained within the abnormal range, nicotine, compared to placebo, significantly shifted EEG towards normal values by reducing slow wave (relative delta and theta) power and augmenting fast (relative alpha-1, alpha-2, beta-1) wave power. No differences were observed between treated and nontreated patients in response to nicotine. The results are discussed in relation to cholinergic and brain arousal systems and their relationship to cognitive processes. Copyright (C) 2000 S. Karger AG, Basel.",
author = "Knott, {Verner J.} and Christopher Engeland and Erich Mohr and Colleen Mahoney and Vadim Ilivitsky",
year = "2000",
month = "1",
day = "1",
doi = "10.1159/000026662",
language = "English (US)",
volume = "41",
pages = "210--220",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "4",

}

Acute nicotine administration in Alzheimer's disease : An exploratory EEG study. / Knott, Verner J.; Engeland, Christopher; Mohr, Erich; Mahoney, Colleen; Ilivitsky, Vadim.

In: Neuropsychobiology, Vol. 41, No. 4, 01.01.2000, p. 210-220.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Acute nicotine administration in Alzheimer's disease

T2 - An exploratory EEG study

AU - Knott, Verner J.

AU - Engeland, Christopher

AU - Mohr, Erich

AU - Mahoney, Colleen

AU - Ilivitsky, Vadim

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Previous findings of cognitive deficits and EEG slowing in Alheimer's patients, together with independent reports of the performance enhancing and electrocortical activating properties of nicotine in normal adults, stimulated this study to examine the acute effects of nicotine on spectrum-analyzed EEG in patients with dementia of the Alzheimer type (DAT). Thirteen patients, 6 currently receiving cholinesterase inhibitor treatment and the remaining being medication free, were administered 2 mg of nicotine polacrilex under randomized, placebo-controlled conditions. Compared to age-regressed EEG norms, the pretreatment EEG spectrums of patients in general were characterized by excessive slow (delta and theta)-wave power, diminished fast (alpha and beta)-wave power and slow mean alpha and total band frequencies. Although postnicotine EEG indices remained within the abnormal range, nicotine, compared to placebo, significantly shifted EEG towards normal values by reducing slow wave (relative delta and theta) power and augmenting fast (relative alpha-1, alpha-2, beta-1) wave power. No differences were observed between treated and nontreated patients in response to nicotine. The results are discussed in relation to cholinergic and brain arousal systems and their relationship to cognitive processes. Copyright (C) 2000 S. Karger AG, Basel.

AB - Previous findings of cognitive deficits and EEG slowing in Alheimer's patients, together with independent reports of the performance enhancing and electrocortical activating properties of nicotine in normal adults, stimulated this study to examine the acute effects of nicotine on spectrum-analyzed EEG in patients with dementia of the Alzheimer type (DAT). Thirteen patients, 6 currently receiving cholinesterase inhibitor treatment and the remaining being medication free, were administered 2 mg of nicotine polacrilex under randomized, placebo-controlled conditions. Compared to age-regressed EEG norms, the pretreatment EEG spectrums of patients in general were characterized by excessive slow (delta and theta)-wave power, diminished fast (alpha and beta)-wave power and slow mean alpha and total band frequencies. Although postnicotine EEG indices remained within the abnormal range, nicotine, compared to placebo, significantly shifted EEG towards normal values by reducing slow wave (relative delta and theta) power and augmenting fast (relative alpha-1, alpha-2, beta-1) wave power. No differences were observed between treated and nontreated patients in response to nicotine. The results are discussed in relation to cholinergic and brain arousal systems and their relationship to cognitive processes. Copyright (C) 2000 S. Karger AG, Basel.

UR - http://www.scopus.com/inward/record.url?scp=0034097530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034097530&partnerID=8YFLogxK

U2 - 10.1159/000026662

DO - 10.1159/000026662

M3 - Article

C2 - 10828731

AN - SCOPUS:0034097530

VL - 41

SP - 210

EP - 220

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 4

ER -